Microglial activation in Alzheimer's disease
- PMID: 19747160
- DOI: 10.2174/156720509790147179
Microglial activation in Alzheimer's disease
Abstract
Alzheimer's disease (AD) is a devastating chronic neurodegenerative disease with currently no available disease modifying treatment. In recent years, the peptide amyloid-beta has been proposed as the major pathogenic force in the development and progression of AD. Microglia, the resident immune and phagocytic cells of the brain, are known to constantly scan brain tissue and to respond to various pathological stimuli. Thus, newly formed plaque composed of A beta seem to activate and recruit microglia in AD transgenic mice. However, the role of microglia is only poorly understood in AD. Microglia may act as a double-edged sword being either detrimental or protective depending on the context. In this mini-review, we discuss the importance of microglia and its receptors in neuroinflammation and plaque clearance. A possible disease modifying role of blood-borne monocytes, which are close relatives of bone-marrow derived microglia, will also be addressed.
Similar articles
-
Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.Int J Neurosci. 2014 May;124(5):307-21. doi: 10.3109/00207454.2013.833510. Epub 2013 Sep 12. Int J Neurosci. 2014. PMID: 23930978 Review.
-
Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.Mol Neurodegener. 2018 May 21;13(1):24. doi: 10.1186/s13024-018-0254-8. Mol Neurodegener. 2018. PMID: 29784049 Free PMC article.
-
Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.Glia. 2016 Dec;64(12):2274-2290. doi: 10.1002/glia.23074. Epub 2016 Sep 23. Glia. 2016. PMID: 27658617
-
Microglia in Alzheimer's Disease.Curr Alzheimer Res. 2020;17(1):29-43. doi: 10.2174/1567205017666200212155234. Curr Alzheimer Res. 2020. PMID: 32048973 Review.
-
A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease.J Mol Cell Biol. 2013 Oct;5(5):284-93. doi: 10.1093/jmcb/mjt028. Epub 2013 Jul 26. J Mol Cell Biol. 2013. PMID: 23892208 Review.
Cited by
-
The small molecule CA140 inhibits the neuroinflammatory response in wild-type mice and a mouse model of AD.J Neuroinflammation. 2018 Oct 11;15(1):286. doi: 10.1186/s12974-018-1321-3. J Neuroinflammation. 2018. PMID: 30309372 Free PMC article.
-
Targeting Microglia in Alzheimer's Disease: From Molecular Mechanisms to Potential Therapeutic Targets for Small Molecules.Molecules. 2022 Jun 27;27(13):4124. doi: 10.3390/molecules27134124. Molecules. 2022. PMID: 35807370 Free PMC article. Review.
-
The role of pro-inflammatory S100A9 in Alzheimer's disease amyloid-neuroinflammatory cascade.Acta Neuropathol. 2014 Apr;127(4):507-22. doi: 10.1007/s00401-013-1208-4. Epub 2013 Nov 16. Acta Neuropathol. 2014. PMID: 24240735 Free PMC article.
-
The TSPO Ligands 2-Cl-MGV-1, MGV-1, and PK11195 Differentially Suppress the Inflammatory Response of BV-2 Microglial Cell to LPS.Int J Mol Sci. 2019 Jan 30;20(3):594. doi: 10.3390/ijms20030594. Int J Mol Sci. 2019. PMID: 30704062 Free PMC article.
-
Microglial priming in Alzheimer's disease.Ann Transl Med. 2018 May;6(10):176. doi: 10.21037/atm.2018.04.22. Ann Transl Med. 2018. PMID: 29951498 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical